Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iHuman (IH) Non-Current Assets (2020 - 2025)

iHuman has reported Non-Current Assets over the past 6 years, most recently at $9.9 million for Q4 2025.

  • Quarterly Non-Current Assets fell 15.45% to $9.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.9 million through Dec 2025, down 15.45% year-over-year, with the annual reading at $10.0 million for FY2025, 12.85% down from the prior year.
  • Non-Current Assets was $9.9 million for Q4 2025 at iHuman, down from $11.7 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $13.4 million in Q4 2021 and troughed at $9.5 million in Q4 2023.
  • The 5-year median for Non-Current Assets is $11.2 million (2022), against an average of $11.1 million.
  • Biggest five-year swings in Non-Current Assets: surged 248.33% in 2021 and later fell 16.43% in 2022.
  • Tracing IH's Non-Current Assets over 5 years: stood at $13.4 million in 2021, then dropped by 16.43% to $11.2 million in 2022, then decreased by 15.55% to $9.5 million in 2023, then increased by 23.46% to $11.7 million in 2024, then decreased by 15.45% to $9.9 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $9.9 million, $11.7 million, and $9.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.